Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.76x is 98% above its 5-year average of -79.34x, near the high end of its 5-year range (-485.58x–-1.76x).
As of the fiscal period ended Monday, March 31, 2025. 71.89% above its 12-month average of -6.26x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2025 (2025-03-31): -1.76x.
INTEREST COVERAGE RATIO
-1.76x
INTEREST COVERAGE RATIO AVG TTM
-6.26x
INTEREST COVERAGE RATIO AVG 3Y
-5.56x
INTEREST COVERAGE RATIO AVG 5Y
-79.34x
INTEREST COVERAGE RATIO AVG 10Y
-94.34x
INTEREST COVERAGE RATIO AVG 15Y
-142.95x
INTEREST COVERAGE RATIO AVG 20Y
-116.58x
CURRENT VS TTM AVG
+71.89%
CURRENT VS 3Y AVG
+68.38%
CURRENT VS 5Y AVG
+97.78%
CURRENT VS 10Y AVG
+98.14%
CURRENT VS 15Y AVG
+98.77%
CURRENT VS 20Y AVG
+98.49%
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 516 covered companies
CURRENT VS SECTOR MEDIAN
+72.40%
vs the sector median at left
Oramed Pharmaceuticals Inc.
Market Cap
$181.63M
Interest Coverage Ratio
-1.76x
TTM Avg
-6.26x
3Y Avg
-5.56x
5Y Avg
-79.34x
Market Cap
$182.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.68M
Interest Coverage Ratio
-709.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.36M
Interest Coverage Ratio
N/A
TTM Avg
57.53x
3Y Avg
57.53x
5Y Avg
57.53x
Market Cap
$176.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$188.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
Interest Coverage Ratio
-48.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.51M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.61M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | $181.63M | -1.76x | -6.26x | -5.56x | -79.34x |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.78M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.68M | -709.33x | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $178.36M | N/A | 57.53x | 57.53x | 57.53x |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.14M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $188.72M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -48.66x | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $172.51M | -36.67x | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $172.61M | -2.21x | 15.94x | 15.94x | 15.94x |
| RxSight, Inc. (RXST)vs › | $191.67M | -1204.75x | N/A | N/A | N/A |
Interest Coverage
-1.8x
Debt/Equity
0.00
Current Ratio
4.98
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-03-31 | -1.76x |
| 2024-06-30 | -12.01x |
| 2024-03-31 | -5.00x |
| 2023-12-31 | -3.20x |
| 2023-09-30 | -3.50x |
| 2022-09-30 | -7.90x |
| 2021-11-30 | -46.06x |
| 2021-08-31 | -11.08x |
| 2021-05-31 | -12.41x |
| 2020-11-30 | -485.58x |
| 2020-05-31 | -284.25x |
| 2020-02-29 | -2018.50x |
| 2019-11-30 | -121.45x |
| 2019-05-31 | -291.29x |
| 2019-02-28 | -187.79x |
| 2018-11-30 | -580.00x |
| 2018-05-31 | -156.34x |
| 2018-02-28 | -141.41x |
| 2017-11-30 | -130.10x |
| 2017-05-31 | -107.75x |
| 2017-02-28 | -160.24x |
| 2016-11-30 | -99.92x |
| 2016-05-31 | -91.74x |
| 2016-02-29 | -56.24x |
| 2015-11-30 | -144.06x |
| 2015-02-28 | -1674.00x |
| 2014-11-30 | -90.57x |
| 2014-08-31 | -1166.16x |
| 2014-05-31 | -456.74x |
| 2014-02-28 | -369.00x |
| 2013-11-30 | -529.57x |
| 2013-05-31 | -213.04x |
| 2013-02-28 | -38.36x |
| 2012-11-30 | -2.45x |
| 2012-05-31 | -52.72x |
| 2012-02-29 | -99.12x |
| 2011-11-30 | -23.82x |
| 2011-08-31 | -113.37x |
| 2011-05-31 | -87.70x |
| 2011-02-28 | -188.58x |
| 2010-11-30 | -179.27x |
| 2010-08-31 | -415.81x |
| 2010-05-31 | -153.75x |
| 2010-02-28 | -137.32x |
| 2009-11-30 | -168.49x |
| 2009-08-31 | -615.54x |
| 2009-02-28 | -31.80x |
| 2008-02-29 | 1.00x |
| 2005-08-31 | 0.02x |
